GlassScriptPhysician profile
Krystyna Bronchard
NPI 1275021552
$12,465.88
in general payments reported to CMS, 2019-2025
32 companies · $5,595 in 2025
The $5,595 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.50 · 2023: $3,487 · 2024: $3,347 · 2025: $5,595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Honoraria: $750 · Education: $287 · Travel and Lodging: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,206.31 |
| Honoraria | $750.00 |
| Education | $286.81 |
| Travel and Lodging | $186.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,565.61 | 2023-2025 | Cardiomems, Ensite, Mitraclip |
| Asahi Intecc USA, INC. | $1,411.15 | 2023-2025 | Asahi Coronary Wires, Asahi Peripheral Vascular Wires, Asahi Ptca Guide Wire |
| Shockwave Medical, INC | $1,392.11 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $1,274.17 | 2023-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,198.82 | 2023-2025 | Jardiance |
| Medtronic, INC. | $828.15 | 2024-2025 | Symplicity G3, Ffrangio, Onyx Frontier |
| Astrazeneca Pharmaceuticals LP | $567.44 | 2023-2024 | Farxiga, Brilinta, Tagrisso |
| Pfizer INC. | $497.64 | 2022-2025 | |
| Boston Scientific Corporation | $494.64 | 2023-2025 | Opticross, General - Vascular Access, Lux-Dx Insertable Cardiac Monitor |
| Philips North America LLC | $447.71 | 2025 | Coronary Other |
| Terumo Medical Corporation | $436.35 | 2025 | Glidewire, Glidesheath Slender, Optitorque |
| Seagen INC. | $319.46 | 2023 | Adcetris |
| Penumbra, INC. | $276.32 | 2023-2024 | Indigo System |
| Abbvie INC. | $243.44 | 2023 | Epkinly, Skyrizi |
| E.R. Squibb & Sons, L.L.C. | $243.13 | 2023-2024 | Opdivo, Camzyos |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $237.66 | 2025 | |
| Kite Pharma, INC. | $224.61 | 2023 | Yescarta |
| Edwards Lifesciences Corporation | $162.81 | 2025 | Sapien 3 Ultra Resilia |
| Beigene USA, INC. | $125.00 | 2023 | Brukinsa |
| Spectrawave, INC | $106.25 | 2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Cook Medical LLC | $57.69 | 2024 | Advance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.35 | 2024 | Lifevest |
| W. L. Gore & Associates, INC. | $50.00 | 2024 | Gore-Tex Vascular Graft |
| Amgen INC. | $50.00 | 2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $32.21 | 2025 | |
| Janssen Pharmaceuticals, INC | $30.50 | 2024 | Xarelto |
| Cordis US Corp. | $29.42 | 2025 | Mynx Control Venous |
| Alnylam Pharmaceuticals INC. | $25.84 | 2023 | Amvuttra |
| Takeda Pharmaceuticals U.S.A., INC. | $23.71 | 2024 | Alunbrig |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Procyrion, INC. | $20.34 | 2024 | |
| Scpharmaceuticals INC. | $18.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystyna Bronchard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.